Researchers at the University of California, Riverside have developed a cheap, simple test that identifies counterfeit and ...

The company, co-founded by 2018 Perelman School of Medicine graduate Christopher Natale and Penn Medicine physician and professor of dermatology Todd Ridky, is developing a pill that provides estrogen ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

After decades of slow progress in understanding and developing effective treatments for Alzheimer’s disease, scientists are ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating ...

Scientists engineered the first fully synthetic brain tissue model. It’s fully functional brain tissue that they can use to test neurological drugs. They believe the discovery will lead them to better ...

HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...